Titan Medical Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
1.01 | 31.52 | -96.8% | -4.35 | -123.15% |
| P/S |
|
0.3904 | 3.24 | -87.95% |
|
|
| P/BV |
|
1.47 | 3.36 | -56.17% |
|
|
| P/FCF |
|
0 | 21.26 | -100% |
|
|
| Ev/Ebitda |
|
0.0783 | 9.95 | -99.21% |
|
|
| Ev/S |
|
0.0458 | 1.88 | -97.57% |
|
|
| Ev/FCF |
|
0.1807 | 19.91 | -99.09% |
|
|
| E/P |
|
0 | 1.47 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
58.48 | 24.35 | 140.16% | -47.32 | -223.58% |
| ROE |
|
146.06 | 13.11 | 1013.81% |
|
|
| ROA |
|
79.76 | 6.14 | 1199.64% |
|
|
| ROIC |
|
0 | 15.56 | -100% |
|
|
| ROS |
|
38.72 | 12.44 | 211.35% |
|
|
| ROCE |
|
216.61 | 14.35 | 1409.81% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.1253 | 6.21 | -97.98% | 0.0678 | +84.97% |
| Nеt Debt/Ebitda |
|
-0.5893 | -5.72 | -89.7% |
|
|
| Debt/Ratio |
|
0.151 | 0.213 | -29.11% |
|
|
| Debt/Equity |
|
0 | 12.45 | -100% |
|
|
| Debt/Net Income |
|
0.1893 | 15.07 | -98.74% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.76 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.21 | -100% | ||
| DSI |
|
0 | 0.7783 | -100% |
|
|
| Average dividend growth |
|
0 | -269.81 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 2.8 | -100% |
|
|
| Average percentage for payments |
|
0 | 246.79 | -100% |
|
|
| Difference from average difference in sector |
|
-1.76 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-10.22 | 132.71 | -107.7% | ||
| Growth impulse Ebitda in 5 years |
|
-118.12 | 100.7 | -217.3% | ||
| Growth impulse Net Income in 5 years |
|
-116.59 | 123.16 | -194.67% | ||
| Growth impulse FCF in 5 years |
|
-109.81 | 88.28 | -224.39% | ||
| Growth impulse EPS in 5 years |
|
-105.67 | 217.84 | -148.51% |
IP Score
5.61/10
